Cortney Caudill

Companies

• Halozyme TherapeuticsChief operating officer Oct 6, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• HTHalozyme Therapeutics HALO7,055 shares²$867.5K at $122.96Mar 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 10, 2026Sold 8,857 shares at $67.64 of Halozyme Therapeutics²
• Mar 10, 2026Exercised options 1,546 shares at $33.51 of Halozyme Therapeutics²
• Mar 9, 2026Sold 2,100 shares at $68.25 of Halozyme Therapeutics²
• Mar 9, 2026Sold 17,900 shares at $67.75 of Halozyme Therapeutics²
• Mar 9, 2026Exercised options 20,000 shares at $33.51 of Halozyme Therapeutics²
• Feb 20, 2026Shares withheld for tax 1,037 shares at $70.98 of Halozyme Therapeutics³
• Feb 20, 2026Exercised options 2,666 shares of Halozyme Therapeutics³
• Nov 1, 2025Sold 4,263 shares at $65.19 of Halozyme Therapeutics⁴
• Nov 1, 2025Exercised options 9,326 shares of Halozyme Therapeutics⁴